N. Mottet

Pulmonary and Respiratory Medicine · 2011–2020

A researcher in the Science corpus: 10 papers; trusts 1 researcher and is trusted by 0 researchers here, as inferred from the citation graph.

Subfields

Whom N. Mottet trusts overall

Their strongest outbound trust, strongest first, inferred from their citations.

  1. Jonathan I. Epstein
  2. Samuel D Searle
  3. Michel Bolla
  4. G. Guyatt

Who trusts N. Mottet overall

  1. M. Hallek

Papers from N. Mottet's perspective

Ordered by how strongly the researchers N. Mottet trusts endorse each paper. Same corpus, a different order for every researcher.

  1. Enzalutamide in Metastatic Prostate Cancer before Chemotherapy (New England Journal of Medicine)
  2. Re: Abiraterone in metastatic prostate cancer without previous chemotherapy. (Journal of Urology)
  3. Screening and prostate cancer mortality: results of the European Randomised Study of Screening for Prostate Cancer (ERSPC) at 13 years of follow-up. (The Lancet)
  4. Denosumab versus zoledronic acid for treatment of bone metastases in men with castration-resistant prostate cancer: a randomised, double-blind study (The Lancet)
  5. AR-V7 and Resistance to Enzalutamide and Abiraterone in Prostate Cancer (New England Journal of Medicine)
  6. Docetaxel plus prednisone or mitoxantrone plus prednisone for advanced prostate cancer. (New England Journal of Medicine)
  7. Screening and prostate-cancer mortality in a randomized European study. (New England Journal of Medicine)
  8. EAU guidelines on prostate cancer. Part 1: screening, diagnosis, and treatment of clinically localised disease. (European Urology)
  9. Radical Prostatectomy or Watchful Waiting in Early Prostate Cancer (New England Journal of Medicine)
  10. MRI-Targeted or Standard Biopsy for Prostate-Cancer Diagnosis (New England Journal of Medicine)

Their papers